Tuesday, July 28, 2026
RSS

Inside BCI

Brain-Computer Interface Industry News
Industry News Research Policy Opinion Market Moves
About Directory Glossary
News

Neuvotion launches first US commercial BCI-platform product this fall

On Monday 27 July 2026, Chad Bouton's Neuvotion announced the first US commercial launch of a product from a brain-computer interface platform. NeuStim NN-01, a wearable neuromuscular stimulator for hand recovery after stroke or C5 spinal cord injury, ships this fall. Neuvotion holds an exclusive worldwide license from the Feinstein Institutes, where Bouton is senior author of the 16 July Nature Medicine paper on the underlying double neural bypass platform. The intracortical BCI half of that platform, tested in one patient (Keith Thomas), remains investigational.

Jul 27, 2026 · 10 min read

Industry News

Precision Neuroscience appoints John Donoghue as scientific advisor

On Thursday 23 July 2026, New York-based Precision Neuroscience announced the appointment of John Donoghue - founding investigator of the BrainGate consortium at Brown, co-founder of Cyberkinetics, and inaugural director of the Wyss Center for Bio and Neuroengineering in Geneva - as a scientific advisor to the company. Donoghue will advise Precision's scientific and engineering teams on device design, signal decoding, and clinical strategy. The appointment lands two days after Precision's non-paralysed cursor-control demonstration across its 15-plus academic-medical-centre clinical network, and at exactly the moment ABILITY Neurotech, the Wyss Center spin-out whose technology was conceived under Donoghue's own directorship, prepares to begin its own chronic first-in-human implantation in ALS patients.

Jul 25 · 9 min read

Industry News

ABILITY Neurotech reaches first-in-human at TUM Munich

On Tuesday 21 July 2026, Geneva-based ABILITY Neurotech announced the first-in-human recording of its fully implantable, batteryless brain-computer interface at TUM University Hospital Rechts der Isar in Munich. The device is a 128-channel sub-scalp ECoG array with a laser-based transcutaneous optical data link streaming raw neural signals through the scalp at 50 megabits per second. The first cohort is up to five brain-tumour surgery patients recording 20 to 30 minutes of intraoperative data each. The company's separate chronic implantation trial in ALS patients at UMC Utrecht, cleared by Dutch regulators on 26 May 2026, has not yet performed a surgery.

Jul 24 · 9 min read

Industry News

AMD patients are reading letters again as PRIMA lands its CE mark in Europe

On Wednesday 22 July 2026, Science Corporation announced the European commercial launch of PRIMA, a two-millimetre subretinal photovoltaic chip that restores functional central vision in patients blinded by geographic atrophy from age-related macular degeneration. The CE mark, granted by DEKRA under the EU Medical Device Regulation, covers 30 European countries. The first commercial implant is expected in Germany. PRIMA is the first CE-marked implant to restore, rather than merely slow, central vision loss in AMD, and the FDA has granted it Humanitarian Use Device designations on the same day. Max Hodak's five-year-old company inherited the technology from Pixium Vision after the French developer's 2024 collapse.

Jul 22 · 11 min read

Industry News

Precision Neuroscience demonstrates thought-based gaming in non-paralysed volunteers

On Tuesday 21 July 2026, Precision Neuroscience announced that neurosurgical patients without paralysis, temporarily implanted with its Layer 7 subdural microelectrode array during scheduled tumor or epilepsy-monitoring procedures, controlled cursors and played Mario Kart, Pong and Fruit Ninja, scrolled Instagram, and answered FaceTime calls with their thoughts. Chief clinical officer Jayme Strauss confirmed the array is removed at bedside in under five minutes at the end of each participant's hospital stay, with the first permanent implant targeted for early 2028.

Jul 21 · 9 min read

Industry News

StairMed's penetrating BCI trial at Huashan reaches 18 cumulative implants

On 20 July 2026, at the World Artificial Intelligence Conference in Shanghai, StairMed disclosed that its cortex-penetrating invasive BCI clinical trial at Huashan Hospital has now reached 18 cumulative implants since March 2025. The Shanghai firm co-founded by Zhao Zhengtuo and Xue Li at the Chinese Academy of Sciences' Center for Excellence in Brain Science demonstrated a patient three months post-op controlling a wheelchair by thought and hitting 6.19 bits per second on a cursor task, alongside a live journalist test at 4.9 bits per second with a finger.

Jul 20 · 9 min read

Industry News

A decade in Nathan Copeland's brain: the Pitt ICMS safety paper lands

On 15 July 2026, Science Translational Medicine published a five-participant, ten-year safety study of intracortical microstimulation in the somatosensory cortex. The Pitt and University of Chicago team led by Robert Gaunt and Charles Greenspon delivered 168 million pulses across 27 combined years of implant time with no serious adverse events. The longest single participant is with very high confidence Nathan Copeland, first implanted on Star Wars Day 2015, still living publicly with the same Utah arrays eleven years later.

Jul 18 · 9 min read

Industry News

Keith Thomas can feel his dog: Feinstein's three-year double neural bypass lands in Nature Medicine

On 16 July 2026, Nature Medicine put on its cover a three-year follow-up of Keith Thomas of Massapequa, New York, who was implanted with five microelectrode arrays in March 2023 as the first participant in the Feinstein Institutes' 'double neural bypass' trial. The Chad Bouton team's paper reports that Thomas can now feed himself, drink from a cup, feel touch on his right wrist, and pet his dog Bow, with strength and sensation gains persisting more than two years after the stimulation was switched off.

Jul 18 · 11 min read

Market Moves

BrainCo unveils a brain-to-robot developer platform at WAIC 2026 in Shanghai

On Friday 17 July 2026, at the World Artificial Intelligence Conference in Shanghai, BrainCo debuted its Brain-Controlled Robot AI Platform, a graphical developer toolkit that pairs its non-invasive EEG headset with third-party humanoid, robotic-arm, and quadruped robots from Unitree, Realman, and Deep Robotics. Nyx He, partner and senior vice president, framed the launch as the next chapter of human-machine collaboration. Live demonstrations at the booth showed a person in an EEG headband directing a robotic arm to pick up a cup and an apple without buttons, voice, or muscle movement.

Jul 18 · 9 min read